[go: up one dir, main page]

MY106120A - Peptide derivatives. - Google Patents

Peptide derivatives.

Info

Publication number
MY106120A
MY106120A MYPI89001655A MYPI19891655A MY106120A MY 106120 A MY106120 A MY 106120A MY PI89001655 A MYPI89001655 A MY PI89001655A MY PI19891655 A MYPI19891655 A MY PI19891655A MY 106120 A MY106120 A MY 106120A
Authority
MY
Malaysia
Prior art keywords
somatostatin
peptide derivatives
detectable element
amino group
group
Prior art date
Application number
MYPI89001655A
Inventor
Dr Steven W J Lamberts Prof
Janos Pless dr
Eric P Krenning Dr
Rainer Albert Dr
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828364A external-priority patent/GB8828364D0/en
Priority claimed from GB898916115A external-priority patent/GB8916115D0/en
Priority claimed from GB898916761A external-priority patent/GB8916761D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY106120A publication Critical patent/MY106120A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SOMATOSTATIN PEPTIDES BEARING AT LEAST ONE CHELATING GROUP FOR A DETECTABLE ELEMENT, SAID CHELATING GROUP BEING LINKED TO AN AMINO GROUP OF SAID PEPTIDE, AND SAID AMINO GROUP HAVING NO SIGNIFICANT BINDING AFFINITY FOR SOMATOSTATIN RECEPTORS, IN FREE OR SALT FORM, ARE COMPLEXED WITH A DETECTABLE ELEMENT AND AS SUCH ARE USEFUL AS A PHARMACEUTICAL, E.G. A RADIOPHARMACEUTICAL FOR IN VIVO IMAGING OF SOMATOSTATIN RECEPTOR POSITIVE TUMORS OR FOR THERAPY.
MYPI89001655A 1988-12-05 1989-11-29 Peptide derivatives. MY106120A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888828364A GB8828364D0 (en) 1988-12-05 1988-12-05 Improvements in/relating to organic compounds
GB898916115A GB8916115D0 (en) 1989-07-13 1989-07-13 Improvements in or relating to organic compounds
GB898916761A GB8916761D0 (en) 1989-07-21 1989-07-21 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
MY106120A true MY106120A (en) 1995-03-31

Family

ID=27264222

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI89001655A MY106120A (en) 1988-12-05 1989-11-29 Peptide derivatives.

Country Status (24)

Country Link
JP (2) JP2726320B2 (en)
KR (1) KR0156541B1 (en)
AT (1) AT403476B (en)
AU (1) AU633859B2 (en)
BE (1) BE1002296A5 (en)
CA (1) CA2004532C (en)
CH (1) CH678329A5 (en)
DE (1) DE3991505B4 (en)
DK (1) DK175338B1 (en)
ES (1) ES2023533A6 (en)
FI (1) FI102540B (en)
FR (1) FR2639947B1 (en)
GB (1) GB2225579B (en)
HK (1) HK189995A (en)
HU (2) HUT53375A (en)
IE (1) IE62091B1 (en)
IL (1) IL92534A (en)
LU (1) LU87633A1 (en)
MY (1) MY106120A (en)
NL (1) NL194828C (en)
PT (1) PT92487B (en)
SA (1) SA96160495B1 (en)
SE (1) SE508799C2 (en)
WO (1) WO1990006949A2 (en)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3845000C2 (en) * 1987-07-10 1998-11-19 Novartis Ag Compsn. contg. somatostatin analogues for treating breast cancer
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
GB9111199D0 (en) * 1991-05-23 1991-07-17 Sandoz Ltd Improvements in or relating to organic compounds
US5985240A (en) * 1989-08-09 1999-11-16 Rhomed Incorporated Peptide radiopharmaceutical applications
US5460785A (en) * 1989-08-09 1995-10-24 Rhomed Incorporated Direct labeling of antibodies and other protein with metal ions
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5700444A (en) * 1992-02-20 1997-12-23 Rhomed Incorporated Chemotactic peptide pharmaceutical applications
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
PT100111B (en) * 1991-02-08 1999-06-30 Biomeasure Inc COMPOSITION FOR THE TREATMENT OF A MAMIFERO SUFFERING FROM PROLIFERATIVE DAPELE, BENIGN OR MALIGNA DISEASE, COMPREHENDING A SOMATOSTATIN ANALOGUE
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
US7238340B1 (en) 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
AU657770B2 (en) * 1991-06-03 1995-03-23 Mallinckrodt Medical, Inc. Radiolabelled somatostatin derivatives, their preparation and use
EP0600992B1 (en) * 1991-08-29 2000-09-20 Mallinckrodt Medical, Inc. Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5738838A (en) * 1992-02-20 1998-04-14 Rhomed Incorporated IKVAV peptide radiopharmaceutical applications
US5556609A (en) * 1992-02-20 1996-09-17 Rhomed Incorporated YIGSR peptide radiopharmaceutical applications
WO1993012819A1 (en) * 1992-01-03 1993-07-08 Rhomed Incorporated Protein- and peptide-metal ion pharmaceutical applications
WO1995000553A1 (en) * 1993-06-23 1995-01-05 Diatech, Inc. Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
EP0642357B1 (en) * 1992-02-05 2001-07-25 Mallinckrodt Inc. Radiolabelled somatostatin
US5371184A (en) * 1992-02-05 1994-12-06 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
AU3967593A (en) * 1992-03-25 1993-10-21 Mallinckrodt Medical, Inc. Method of intraoperatively detecting and locating tumoral tissues
US5620675A (en) * 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
NO940080L (en) * 1993-01-12 1994-07-13 Sandoz Ag Polypeptides, methods of their preparation and pharmaceutical preparations thereof
WO1994017829A1 (en) * 1993-02-02 1994-08-18 Neorx Corporation Directed biodistribution of small molecules
US5879657A (en) * 1993-03-30 1999-03-09 The Dupont Merck Pharmaceutical Company Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
GB9417873D0 (en) * 1994-09-06 1994-10-26 Sandoz Ltd Organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
US5830431A (en) * 1995-06-07 1998-11-03 Mallinckrodt Medical, Inc. Radiolabeled peptide compositions for site-specific targeting
GB9708265D0 (en) 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
FI965181A7 (en) * 1996-12-20 1998-06-21 Map Medical Tech Oy Polyalcohol-peptide derivatives
US6630570B1 (en) 1999-04-09 2003-10-07 Insitut für Diagnostikforschung GmbH Short-chain peptide-dye conjugates as contrast media for optical diagnosis
US7175953B2 (en) 1999-04-09 2007-02-13 Institute Fuer Diagnostik Forschung Short-warp peptide-dye conjugate as contrast agent for optical diagnostic
DE19917713A1 (en) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Short-chain peptide-dye conjugates as contrast agents for optical diagnostics
US6685914B1 (en) 1999-09-13 2004-02-03 Bristol-Myers Squibb Pharma Company Macrocyclic chelants for metallopharmaceuticals
EP1381396B1 (en) * 2001-04-23 2009-04-01 Mallinckrodt Inc. Tc and re labeled radioactive glycosylated octreotide derivatives
US7968080B2 (en) 2003-08-20 2011-06-28 The Regents Of The University Of California Somatostatin analogs with inhibitory activity to growth hormone release
JP5395327B2 (en) * 2003-09-17 2014-01-22 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム Mechanism-based targeted pancreatic beta cell imaging and therapy
EP2067786A1 (en) 2007-12-07 2009-06-10 ITALFARMACO S.p.A. Novel non selective analogs of somatostatin
WO2014081655A1 (en) 2012-11-21 2014-05-30 Serene Oncology, Llc Tin-1 17m comprising somatostatin receptor binding compounds
CN119708199A (en) 2023-09-27 2025-03-28 钱杭江医药科技(嘉兴)有限公司 Somatostatin peptide analogue, chelate and application thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments
US4652519A (en) * 1983-02-03 1987-03-24 Yeda Research And Development Company Limited Bifunctional chelating agents and process for their production
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
DE3511206A1 (en) * 1985-03-28 1986-10-09 Sandoz-Patent-GmbH, 7850 Lörrach Polypeptide derivatives, their preparation and pharmaceutical products which contain these polypeptide derivatives
DE3522638A1 (en) * 1985-06-25 1987-01-08 Diamalt Ag NEW SOMATOSTATIN DERIVATIVES
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
DK172629B1 (en) * 1986-02-14 1999-03-22 Nihon Mediphysics Co Ltd Reactive high molecular weight compounds with at least one free amino group, high molecular weight compounds combined with a physiological
US4732974A (en) * 1986-03-05 1988-03-22 Mallinckrodt, Inc. Metal ion labeling of carrier molecules
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
HU906340D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Synthesis in solid phase for producing peptonic alcohols
CH679045A5 (en) * 1987-06-29 1991-12-13 Sandoz Ag
US5073541A (en) * 1987-11-18 1991-12-17 Administrators Of The Tulane Educational Fund Treatment of small cell lung cancer with somatostatin analogs
FR2638968B1 (en) * 1988-11-11 1994-10-07 Sandoz Sa NEW THERAPEUTIC USE OF SOMATOSTATIN AND ITS ANALOGS AND DERIVATIVES

Also Published As

Publication number Publication date
IL92534A (en) 1994-06-24
GB2225579A (en) 1990-06-06
DK175338B1 (en) 2004-08-30
AU633859B2 (en) 1993-02-11
FR2639947B1 (en) 1995-04-21
JP2726320B2 (en) 1998-03-11
CH678329A5 (en) 1991-08-30
HK189995A (en) 1995-12-29
ES2023533A6 (en) 1992-01-16
WO1990006949A2 (en) 1990-06-28
ATA901789A (en) 1997-07-15
SE8904087D0 (en) 1989-12-04
FI102540B1 (en) 1998-12-31
BE1002296A5 (en) 1990-11-20
IE62091B1 (en) 1994-12-14
WO1990006949A3 (en) 1990-07-26
FI102540B (en) 1998-12-31
DK612689A (en) 1990-06-06
AT403476B (en) 1998-02-25
FR2639947A1 (en) 1990-06-08
PT92487A (en) 1990-06-29
JPH02184698A (en) 1990-07-19
IE893866L (en) 1990-06-05
NL8902981A (en) 1990-07-02
KR0156541B1 (en) 1998-10-15
CA2004532A1 (en) 1990-06-05
GB2225579B (en) 1993-03-17
NL194828B (en) 2002-12-02
JP3686503B2 (en) 2005-08-24
SE508799C2 (en) 1998-11-09
HU211468A9 (en) 1995-11-28
KR900009697A (en) 1990-07-05
FI895809A0 (en) 1989-12-04
PT92487B (en) 1996-01-31
LU87633A1 (en) 1991-09-18
SE8904087L (en) 1991-06-05
GB8927255D0 (en) 1990-01-31
NL194828C (en) 2003-04-03
HU896359D0 (en) 1990-02-28
CA2004532C (en) 2000-02-22
JPH1095737A (en) 1998-04-14
DK612689D0 (en) 1989-12-05
AU4587189A (en) 1990-06-14
DE3991505B4 (en) 2006-04-20
HUT53375A (en) 1990-10-28
SA96160495B1 (en) 2006-08-23

Similar Documents

Publication Publication Date Title
MY106120A (en) Peptide derivatives.
IL95118A0 (en) Polypeptide derivatives,their preparation and pharmaceutical compositions containing them
Wilkinson Troponin C from rabbit slow skeletal and cardiac muscle is the product of a single gene
US5225180A (en) Technetium-99m labeled somatostatin-derived peptides for imaging
US5814298A (en) Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
ZA954547B (en) Technetium-99m labeled peptides for imaging
GR3026658T3 (en) Hydrazino-type radionuclide chelators having an n 3?s configuration
Elzinga et al. The primary structure of actin from rabbit skeletal muscle. Five cyanogen bromide peptides, including the NH2 and COOH termini.
ATE184203T1 (en) TECHNETIUM-99M LABELED PEPTIDES FOR IMAGING
DE69635080D1 (en) RADIOMETALL-BINDING ANALOGS FROM LHRH
EP0877760A4 (en)
IL96043A0 (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
GB9108652D0 (en) Immunoreactive compounds
ATE380038T1 (en) RADIOMETALL-BINDING PEPTIDE ANALOGUE
AU7528894A (en) Hydrazino-type n2s2 chelators
DE69434384D1 (en) METALKOMPLEXBILDNER
BG103872A (en) Glycoconjugates of 20(s)-camptotecin
CA2069638A1 (en) Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
GR1002475B (en) Method for preparing peptidic derivatives
EP0264953A3 (en) Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use
AU3602695A (en) Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
Kikuchi et al. Effect of insulin fragments on biological activity of insulin and desoctapeptide insulin. I. Potentiation of biological activities.
FI943306L (en) Method for preparing a ligand complexed with a pharmaceutically usable radionuclide
ES2009274A6 (en) Synthesis of glyco-enkephalin derivs. of hyp5